CONOCOPHILLIPS Cash & Equivalents 2006-2025 | COP
Beta
What is cash & equivalents?
Cash and cash equivalents can be defined as the most liquid assets on a company's balance sheet, including cash on hand and short-term investments maturing within 90 days.
What is CONOCOPHILLIPS's current cash & equivalents?
CONOCOPHILLIPS (COP) annual cash & equivalents for 2024 was $5.61B, a 0.50% decline from 2023. CONOCOPHILLIPS cash & equivalents for the quarter ending September 30, 2025 was $5.26B.
What was CONOCOPHILLIPS's cash & equivalents in 2023?
CONOCOPHILLIPS annual cash & equivalents for 2023 was $5.63B, a 12.74% decline from 2022.
What was CONOCOPHILLIPS's cash & equivalents in 2022?
CONOCOPHILLIPS annual cash & equivalents for 2022 was $6.46B, a 28.44% increase from 2021.
What is CONOCOPHILLIPS's 5-year cash & equivalents CAGR?
CONOCOPHILLIPS cash & equivalents grew at a compound annual growth rate (CAGR) of 1.96% from FY2019 to FY2024, going from $5.09B to $5.61B over 5 years.
Cash & Equivalents History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR+2.0%
FY2019
$5.09B
→
FY2024
$5.61B
06070809101112131415161718192021222324
5 years selected
Cash & Equivalents History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2024 | $5.61B | -0.5% | 10-K |
| FY2023 | $5.63B | -12.7% | 10-K |
| FY2022 | $6.46B | +28.4% | 10-K |
| FY2021 | $5.03B | +68.1% | 10-K |
| FY2020 | $2.99B | -41.2% | 10-K |
| FY2019 | $5.09B | -14.0% | 10-K |
| FY2018 | $5.92B | -6.5% | 10-K |
| FY2017 | $6.33B | +75.2% | 10-K |
| FY2016 | $3.61B | +52.4% | 10-K |
| FY2015 | $2.37B | -53.2% | 10-K |
| FY2014 | $5.06B | -19.0% | 10-K |
| FY2013 | $6.25B | +72.6% | 10-K |
| FY2012 | $3.62B | -37.4% | 10-K |
| FY2011 | $5.78B | -38.9% | 10-K |
| FY2010 | $9.45B | +1644.3% | 10-K |
| FY2009 | $542.0M | -28.2% | 10-K |
| FY2008 | $755.0M | -48.1% | 10-K |
| FY2007 | $1.46B | +78.2% | 10-K |
| FY2006 | $817.0M | - | 10-K |